Specialty Pharmacy

Archival tumor tissue reliably identifies patients with folate receptor alpha-positive ovarian cancer.

Ribociclib plus letrozole improved progression free survival in patients with HR+/HER2 advanced or metastatic breast cancer.

Top news of the day from across the health care landscape.

New National Association of Specialty Pharmacy executive director discusses potential changes to the specialty pharmacy landscape.

Under the AHCA, states would receive a lower level of federal funding for new beneficiaries.

Novel drug well-tolerated in patients with active RA who were refractory.

BET-inhibitors and immune-based treatments may improve outcomes in patients with blood cancer.

Mark A. Vineis, vice president of specialty pharmacy at Cardinal Health, discusses the elements of a successful therapy management program in specialty pharmacy.

Fatigue and limitations in leg function may increase progress from relapsing-remitting MS to secondary progressive MS in older adults.

Top news of the day from across the health care landscape.

Expedited drug approvals may become a reality if Scott Gottlieb confirmed as head of FDA.

Genital herpes is associated with increased risk of HIV transmission.

Target may lead to the development of new drugs that inhibit cancer.

Top articles of the week on Specialty Pharmacy Times.

Conversational messaging tools improve healthy behavior and boost patient outcomes.

A regulatory protein that weakens the immune response to viral RNA presents a new treatment target for cancer.

Extracellular matrix receptors shield cancer cells from harsh environments.

Non-inferiority found between tenofovir disoproxil fumarate and tenofovir alafenamide regimens.

Top news of the day across the health care landscape.

Possible association found between high mercury exposure and ALS.

Individuals with MS are 3 to 6 times more likely to develop seizures.

Protein once thought to suppress tumors in acute myeloid leukemia may instead promote the disease.

Players in the pharmaceutical supply chain have come under scrutiny as legislators target high drug costs.

Compounds demonstrate high cancer-killing activity and low-toxicity in non-tumor cell line.

A mother’s immune response to anti-herpes simplex virus-2 may disrupt development of fetal central nervous system.

Targeted and individualized breast cancer treatment is viable.

Long-term metformin therapy associated with lower serum vitamin B12 concentration.

Children with the C9orf72 mutation are affected with these diseases at a younger age than the parent.